NexImmune News - NEXI

Company Name	Stock Ticker Symbol	Market	Type
NexImmune Inc	NEXI	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.17	-4.96%	3.26	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
3.48	3.26	3.48	3.26	3.43

more quote information »

Recent News

Date	Time	Source	Heading
3/07/2024	13:20	BW	Konzernergebnis zum 31. Dezember 2023 genehmigt, starke..
3/07/2024	12:33	BW	Approbation des résultats financiers du groupe au 31..
3/07/2024	01:31	BW	Approvati i risultati finanziari di Gruppo al 31 dicembre..
3/07/2024	01:30	BW	Group Financial Results as of December 31st 2023 Approved,..
2/06/2024	16:42	GLOBE	NexImmune Announces Closing of $3.67 Million Registered..
2/06/2024	16:30	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2/05/2024	17:10	EDGAR2	Form 8-K - Current report
2/05/2024	16:34	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/02/2024	14:00	GLOBE	NexImmune Announces $3.67 Million Registered Direct Offering..
2/02/2024	13:25	EDGAR2	Form 8-K - Current report
2/01/2024	09:17	EDGAR2	Form 8-K - Current report
1/19/2024	16:43	EDGAR2	Form 8-K - Current report
1/18/2024	16:43	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/22/2023	16:01	EDGAR2	Form 8-K - Current report
12/01/2023	13:39	EDGAR2	Form 8-K - Current report
11/22/2023	17:40	EDGAR2	Form 144/A - Report of proposed sale of securities: [Amend]
11/22/2023	17:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	16:39	EDGAR2	Form 144 - Report of proposed sale of securities
11/20/2023	17:19	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/20/2023	17:01	EDGAR2	Form 8-K/A - Current report: [Amend]
11/17/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/15/2023	16:17	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
11/09/2023	17:47	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/09/2023	09:35	BW	Finanzergebnisse der Gruppe zum 30. September 2023..
11/09/2023	08:52	BW	Les résultats financiers du groupe au 30 septembre 2023 ont..
11/09/2023	01:30	BW	Approvati I Risultati Finanziari Di Gruppo Al 30 Settembre..
11/02/2023	17:12	EDGAR2	Form 8-K - Current report
11/02/2023	16:33	EDGAR2	Form 8-K - Current report
10/24/2023	08:00	GLOBE	NexImmune, Yale, and JDRF Extend Research Partnership for..
10/19/2023	08:00	GLOBE	NexImmune Announces Presentations at The Society for..
10/18/2023	16:15	EDGAR2	Form 8-K - Current report
10/18/2023	11:30	GLOBE	NexImmune Announces 1-for-25 Reverse Stock Split
9/25/2023	16:42	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/15/2023	16:06	EDGAR2	Form 8-K - Current report
9/13/2023	17:14	EDGAR2	Form PRE 14A - Other preliminary proxy statements
9/08/2023	19:23	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/31/2023	17:11	EDGAR2	Form 8-K - Current report
8/31/2023	16:45	GLOBE	NexImmune Announces Workforce Reduction to Enable Continued..
8/10/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:06	EDGAR2	Form 8-K - Current report
8/10/2023	16:01	GLOBE	NexImmune Reports Second Quarter 2023 Financial Results and..
8/01/2023	18:21	BW	Finanzergebnisse der Gruppe zum 30. Juni 2023 bestätigen..
8/01/2023	01:23	BW	Group Financial Results as of June 30th 2023, Approved Solid..
7/07/2023	16:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/05/2023	08:01	GLOBE	NexImmune Presents Initial Positive Data from the NEXI-001..
5/22/2023	16:01	GLOBE	NexImmune Announces Poster Presentation at the 2023 FOCIS..
5/15/2023	16:01	GLOBE	NexImmune Reports First Quarter 2023 Financial Results and..